Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures

ObjectiveTo establish and characterize a diverse library of head and neck squamous cell cancer (HNSCC) cultures using conditional reprogramming (CR).MethodsPatients enrolled on an IRB-approved protocol to generate tumor cell cultures using CR methods. Tumor and blood samples were collected and clinical information was recorded. Successful CR cultures were validated against banked reference tumors with short tandem repeat genotyping. Cell morphology was archived with photodocumentation. Clinical and demographic factors were evaluated for associations with successful establishment of CR culture. Human papilloma virus (HPV) genotyping, clonogenic survival, MTT assays, spheroid growth, and whole exome sequencing were carried out in selected cultures.ResultsForty four patients were enrolled, with 31 (70%) successful CR cultures, 32% derived from patients who identified as Black and 61% as Hispanic. All major head and neck disease sites were represented, including 15 (48%) oral cavity and 8 (26%) p16-positive oropharynx cancers. Hispanic ethnicity and first primary tumors (vs. second primary or recurrent tumors) were significantly associated with successful CR culture. HPV expression was conserved in CR cultures, including CR-024, which carried a novel HPV-69 serotype. CR cultures were used to test cisplatin responses using MTT assays. Previous work has also demonstrated these models can be used to assess response to radiation and can be engrafted in mouse models. Whole exome sequencing demonstrated that CR cultures preserved tumor mutation burden and driver mutations.ConclusionCR culture is highly successful in propagating HNSCC cells. This study included a high proportion of patients from underrepresented minority groups.Level of EvidenceNot Applicable Laryngoscope, 2024 Head and neck squamous cell cancer cell lines were created with a process called 'conditional reprogramming', which allows researchers to grow cancer cells to study them. 31 cell lines were successfully created, from several head and neck cancer sites, and from patients of diverse racial and ethnic backgrounds. image